Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
BAC Bank of America Corp
CANQF CanaQuest Medical Corp
FRSHY China Jinmao Holdings Group Ltd
EQH-C Equitable Holdings Inc
IBTX Independent Bank Group Inc
DLTR Dollar Tree Inc
FRTX Fresh Tracks Therapeutics Inc
PLXS Plexus Corp
YEXT Yext Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Closing Price
$168.23
Day's Change
-0.66 (-0.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
168.87
Day's Low
167.77
Volume
(Below Average)
Volume:
6,058,104

10-day average volume:
7,099,087
6,058,104

Johnson & Johnson Stock Rises Thursday, Still Underperforms Market

4:33 pm ET November 10, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Johnson & Johnson (JNJ) rose 1.17% to $174.47 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 5.54% to 3,956.37 and the Dow Jones Industrial Average rising 3.70% to 33,715.37. Johnson & Johnson closed $12.22 below its 52-week high ($186.69), which the company achieved on April 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. fell 0.38% to $324.75, Merck & Co. Inc. (MRK) rose 0.30% to $101.89, and Pfizer Inc. (PFE) rose 1.41% to $47.38. Trading volume (7.4 M) eclipsed its 50-day average volume of 7.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 10, 2022.

	

(END) Dow Jones Newswires

November 10, 2022 16:33 ET (21:33 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.